Keywords: Roche, Medingo, Insulin delivery, Diabetes

Roche acquires Medingo for $160 million to expands its position in the growing insulin delivery systems market

Article | 15 April 2010

Print This

Swiss drug major Roche has agreed with Israel’s Elron Electronics to acquire 100% of its majority-owned subsidiary Medingo, which is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in